Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine
Open Access
Abstract
The emergence of induced pluripotent stem cell (iPSC) technology has had a great impact on the field of medicine ever since the ground-breaking discovery in 2006 that overexpression of four specific transcription factors was able to turn back the developmental clock of somatic cells into an embryonic-like state. The resulting iPSCs carry the developmental potential of human embryonic stem cells (hESC) without the embryo and have been heralded as a powerful tool to study development and disease. This technology has made it possible for the first time for researchers to transform end-differentiated cells from a particular individual into another cell type that remains specific to that individual, paving the way for novel methods of in vitro disease modelling and therapeutic applications. This paper reviews some of the key areas in cardiovascular medicine in which iPSC technology has been applied and discusses the future directions and ongoing challenges ahead in this exciting field.Keywords
This publication has 51 references indexed in Scilit:
- In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger NucleasesStem Cells, 2011
- Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsNature, 2011
- Harnessing the potential of induced pluripotent stem cells for regenerative medicineNature Cell Biology, 2011
- Recapitulation of premature ageing with iPSCs from Hutchinson–Gilford progeria syndromeNature, 2011
- Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndromeNature, 2011
- Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined FactorsCell, 2010
- Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndromeNature, 2010
- Biohybrid thin films for measuring contractility in engineered cardiovascular muscleBiomaterials, 2010
- Induced pluripotent stem cells from a spinal muscular atrophy patientNature, 2008
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006